Guanxinjing ameliorates coronary microvascular dysfunction in myocardial ischemia-reperfusion injury by alleviating inflammation and restoring endothelial function

BackgroundCoronary microvascular dysfunction (CMD) secondary to myocardial ischemia-reperfusion injury (MIRI) is characterized by profound inflammatory activation and endothelial impairment. Guanxinjing compound (GXJC) is a clinical drug widely used for coronary heart disease and angina pectoris clo...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Yaoting Wang, Lan Li, Liang Jin, Shikai Zhan, Hai Ren, Jiao Zhao, Qiuru Wang, Yiqiong Wang, Shudong Lin, Jiaxing Xin, Yao Dai, Yifan Zhou, Ting Zhang, Qian Liu, Yunyun Lu, Yiqi Zhu, Jiangyue Wu, Jiayan Lin, Shujing Zhang, Ling Zhang
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	Frontiers Media S.A. 2026-07-01
श्रृंखला:	Frontiers in Immunology
विषय:	endothelial function GuanXinJing inflammation microcirculation myocardial ischemia-reperfusion injury
ऑनलाइन पहुंच:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1846953/full
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!